The significance of quercetin-loaded advanced nanoformulations for the management of diabetic wounds

References

• 1. Wan R, Weissman JP, Grundman K et al. Diabetic wound healing: the impact of diabetes on myofibroblast activity and its potential therapeutic treatments. Wound Repair Regen. 29(4), 573–581 (2021).
  MedlineGoogle Scholar
• 2. Fu J, Huang J, Lin M et al. Quercetin promotes diabetic wound healing via switching macrophages from M1 to M2 polarization. J. Surg. Res. 246, 213–223 (2020).
  Medline CASGoogle Scholar
• 3. Kant V, Jangir BL, Sharma M et al. Topical application of quercetin improves wound repair and regeneration in diabetic rats. Immunopharmacol. Immunotoxicol. 43(5), 536–553 (2021).
  Medline CASGoogle Scholar
• 4. Bai Q, Han K, Dong K et al. Potential applications of nanomaterials and technology for diabetic wound healing. Int. J. Nanomed. 15, 9717–9743 (2020).
  Medline CASGoogle Scholar
• 5. Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J. Ophthalmol. 69(11), 2932–2938 (2021).
  MedlineGoogle Scholar
• 6. Ighodaro OM. Molecular pathways associated with oxidative stress in diabetes mellitus. Biomed. Pharmacother. 108, 656–662 (2018).
  Medline CASGoogle Scholar
• 7. Wadhwa K, Kadian V, Puri V et al. New insights into quercetin nanoformulations for topical delivery. Phytomedicine Plus 2(2), 100257 (2022).
  Google Scholar
• 8. Vilian AE, Puthiaraj P, Kwak CH et al. Electrochemical determination of quercetin based on porous aromatic frameworks supported Au nanoparticles. Electrochimica Acta. 216, 181–187 (2016).
  CASGoogle Scholar
• 9. Gao Y, Wang Y, Ma Y et al. Formulation optimization and in situ absorption in rat intestinal tract of quercetin-loaded microemulsion. Colloids Surf. B Biointerfaces 71(2), 306–314 (2009).
  Medline CASGoogle Scholar
• 10. Qi M, Zhou Q, Zeng W et al. Growth factors in the pathogenesis of diabetic foot ulcers. Front. Biosci. Landmark 23(2), 310–317 (2018).
  Medline CASGoogle Scholar
• 11. Kant V, Sharma M, Jangir BL, Kumar V. Acceleration of wound healing by quercetin in diabetic rats requires mitigation of oxidative stress and stimulation of the proliferative phase. Biotechnic Histochem. 97(6), 461–472 (2022).
  Medline CASGoogle Scholar
• 12. Ahmad M, Sultana M, Raina R et al. Hypoglycemic, hypolipidemic, and wound healing potential of quercetin in streptozotocin-induced diabetic rats. Pharmacogn. Mag. 13(Suppl. 3), S633–S639 (2017).
  MedlineGoogle Scholar
• 13. Padhi S, Nayak AK, Behera A. Type II diabetes mellitus: a review on recent drug based therapeutics. Biomed. Pharmacother. 131, 110708 (2020).
  Medline CASGoogle Scholar
• 14. Uppal S, Italiya KS, Chitkara D, Mittal A. Nanoparticulate-based drug delivery systems for small molecule anti-diabetic drugs: an emerging paradigm for effective therapy. Acta Biomater. 81, 20–42 (2018).
  Medline CASGoogle Scholar
• 15. Vicentini FT, Simi TR, Del Ciampo JO et al. Quercetin in w/o microemulsion: in vitro and in vivo skin penetration and efficacy against UVB-induced skin damages evaluated in vivo. Eur. J. Pharm. Biopharm. 69(3), 948–957 (2008).
  Medline CASGoogle Scholar
• 16. Liu D, Hu H, Lin Z et al. Quercetin deformable liposome: preparation and efficacy against ultraviolet B induced skin damages in vitro and in vivo. J. Photochem. Photobiol. Biol. 127, 8–17 (2013).
  Medline CASGoogle Scholar
• 17. Hasan N, Imran M, Sheikh A et al. Cannabis as a potential compound against various malignancies, legal aspects, advancement by exploiting nanotechnology and clinical trials. J. Drug Target. 30(7), 709–725 (2022).
  Medline CASGoogle Scholar
• 18. Rai VK, Mishra N, Yadav KS, Yadav NP. Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications. J. Control. Rel. 270, 203–225 (2018).
  Medline CASGoogle Scholar
• 19. Tapfumaneyi P, Imran M, Mohammed YH, Roberts M. Recent advances and future prospective of topical and transdermal delivery systems. Front. Drug Deliv. 2, 957732 doi: 10.3389/fddev.2022.957732 (2022).
  Google Scholar
• 20. Kong M, Chen XG, Kweon DK, Park HJ. Investigations on skin permeation of hyaluronic acid based nanoemulsion as transdermal carrier. Carbohydrate Polymers 86(2), 837–843 (2011).
  CASGoogle Scholar
• 21. Yilmaz E, Borchert H-H. Design of a phytosphingosine-containing, positively-charged nanoemulsion as a colloidal carrier system for dermal application of ceramides. Eur. J. Pharm. Biopharm. 60(1), 91–98 (2005).
  Medline CASGoogle Scholar
• 22. Bose S, Michniak-Kohn B. Preparation and characterization of lipid based nanosystems for topical delivery of quercetin. Eur. J. Pharm. Sci. 48(3), 442–452 (2013).
  Medline CASGoogle Scholar
• 23. Park JW, Hwang SR, Yoon I-S. Advanced growth factor delivery systems in wound management and skin regeneration. Molecules. 22(8), 1259 (2017).
  MedlineGoogle Scholar
• 24. Pereira RF, Bartolo PJ. Traditional therapies for skin wound healing. Adv. Wound Care 5(5), 208–229 (2016).
  Google Scholar
• 25. Groeber F, Holeiter M, Hampel M et al. Skin tissue engineering – in vivo and in vitro applications. Adv. Drug Deliv. Rev. 63(4–5), 352–366 (2011).
  Medline CASGoogle Scholar
• 26. Guo S, DiPietro LA. Factors affecting wound healing. J. Dental Res. 89(3), 219–229 (2010).
  Medline CASGoogle Scholar
• 27. Krasner D. Minimizing factors that impair wound healing: a nursing approach. Ostomy/Wound Manage. 41(1), 22–26; 28, 30; quiz 31 (1995).
  Medline CASGoogle Scholar
• 28. Witte MB, Barbul A. General principles of wound healing. Surg. Clin. North Am. 77(3), 509–528 (1997).
  Medline CASGoogle Scholar
• 29. Okonkwo UA, DiPietro LA. Diabetes and wound angiogenesis. Int. J. Mol. Sci. 18(7), 1419 (2017).
  MedlineGoogle Scholar
• 30. Zhao R, Liang H, Clarke E et al. Inflammation in chronic wounds. Int. J. Mol. Sci. 17(12), 2085 (2016).
  MedlineGoogle Scholar
• 31. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J. Clin. Invest. 117(5), 1219–1222 (2007).
  Medline CASGoogle Scholar
• 32. Hassan WU, Greiser U, Wang W. Role of adipose-derived stem cells in wound healing. Wound Repair Regen. 22(3), 313–325 (2014).
  MedlineGoogle Scholar
• 33. Kato J, Kamiya H, Himeno T et al. Mesenchymal stem cells ameliorate impaired wound healing through enhancing keratinocyte functions in diabetic foot ulcerations on the plantar skin of rats. J. Diabetes Complications 28(5), 588–595 (2014).
  MedlineGoogle Scholar
• 34. Kota SK, Meher LK, Jammula S et al. Aberrant angiogenesis: the gateway to diabetic complications. Indian J. Endocrinol. Metab. 16(6), 918 (2012).
  MedlineGoogle Scholar
• 35. Ellis S, Lin EJ, Tartar D. Immunology of wound healing. Curr. Dermatol. Rep. 7(4), 350–358 (2018).
  MedlineGoogle Scholar
• 36. Cañedo-Dorantes L, Cañedo-Ayala M. Skin acute wound healing: a comprehensive review. Int. J. Inflamm. 2019, 3706315 (2019).
  MedlineGoogle Scholar
• 37. Raziyeva K, Kim Y, Zharkinbekov Z et al. Immunology of acute and chronic wound healing. Biomolecules 11(5), 700 (2021).
  Medline CASGoogle Scholar
• 38. Larouche J, Sheoran S, Maruyama K, Martino MM. Immune regulation of skin wound healing: mechanisms and novel therapeutic targets. Adv. Wound Care 7(7), 209–231 (2018).
  Google Scholar
• 39. Han G, Ceilley R. Chronic wound healing: a review of current management and treatments. Adv. Ther. 34(3), 599–610 (2017).
  MedlineGoogle Scholar
• 40. Badhwar R, Mangla B, Neupane YR et al. Quercetin loaded silver nanoparticles in hydrogel matrices for diabetic wound healing. Nanotechnology 32(50), 1–13 (2021).
  Google Scholar
• 41. Ayyanar M, Ignacimuthu S. Herbal medicines for wound healing among tribal people in southern India: ethnobotanical and scientific evidences. Int. J. Appl. Res. Nat. Prod. 2(3), 29–42 (2009).
  Google Scholar
• 42. Maver T, Maver U, Stana Kleinschek K et al. A review of herbal medicines in wound healing. Int. J. Dermatol. 54(7), 740–751 (2015).
  MedlineGoogle Scholar
• 43. Kwakman PH, Zaat SA. Antibacterial components of honey. IUBMB Life 64(1), 48–55 (2012).
  Medline CASGoogle Scholar
• 44. Leyden JJ, Kligman AM. Contact dermatitis to neomycin sulfate. JAMA 242(12), 1276–1278 (1979).
  Medline CASGoogle Scholar
• 45. Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H. Topical silver for preventing wound infection. Cochrane Database Syst. Rev. (3), CD006478 (2010).
  MedlineGoogle Scholar
• 46. Alexiadou K, Doupis J. Management of diabetic foot ulcers. Diabetes Ther. 3(1), 1–15 (2012).
  Google Scholar
• 47. Boateng JS, Matthews KH, Stevens HN, Eccleston GM. Wound healing dressings and drug delivery systems: a review. J. Pharm. Sci. 97(8), 2892–2923 (2008).
  Medline CASGoogle Scholar
• 48. Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. New Engl. J. Med. 334(25), 1642–1648 (1996).
  Medline CASGoogle Scholar
• 49. Caldwell MD. Bacteria and antibiotics in wound healing. Surg. Clin. 100(4), 757–776 (2020).
  MedlineGoogle Scholar
• 50. Brett D. A review of collagen and collagen-based wound dressings. Wounds 20(12), 347–356 (2008).
  MedlineGoogle Scholar
• 51. Singh O, Gupta SS, Soni M et al. Collagen dressing versus conventional dressings in burn and chronic wounds: a retrospective study. J. Cutan. Aesthet. Surg. 4(1), 12 (2011).
  MedlineGoogle Scholar
• 52. Mi Y, Zhong L, Lu S et al. Quercetin promotes cutaneous wound healing in mice through Wnt/beta-catenin signaling pathway. J. Ethnopharmacol. 290, 115066 (2022).
  Medline CASGoogle Scholar
• 53. Hara M, Verkman A. Glycerol replacement corrects defective skin hydration, elasticity, and barrier function in aquaporin-3-deficient mice. Proc. Natl Acad. Sci. 100(12), 7360–7365 (2003).
  Medline CASGoogle Scholar
• 54. Hatahet T, Morille M, Hommoss A et al. Quercetin topical application, from conventional dosage forms to nanodosage forms. Eur. J. Pharm. Biopharm. 108, 41–53 (2016).
  Medline CASGoogle Scholar
• 55. Lee HN, Shin SA, Choo GS et al. Anti-inflammatory effect of quercetin and galangin in LPS-stimulated RAW264. 7 macrophages and DNCB-induced atopic dermatitis animal models. Int. J. Mol. Med. 41(2), 888–898 (2018).
  Medline CASGoogle Scholar
• 56. Terao J, Piskula M, Yao Q. Protective effect of epicatechin, epicatechin gallate, and quercetin on lipid peroxidation in phospholipid bilayers. Arch. Biochem. Biophys. 308(1), 278–284 (1994).
  Medline CASGoogle Scholar
• 57. Park YR, Sultan MT, Park HJ et al. NF-kappaB signaling is key in the wound healing processes of silk fibroin. Acta Biomater. 67, 183–195 (2018).
  Medline CASGoogle Scholar
• 58. Yang HL, Tsai YC, Korivi M et al. Lucidone promotes the cutaneous wound healing process via activation of the PI(3)K/AKT, Wnt/beta-catenin and NF-kappaB signaling pathways. Biochim. Biophys. Acta Mol. Cell. Res. 1864(1), 151–168 (2017).
  Medline CASGoogle Scholar
• 59. Xuan Y, Chi L, Tian H et al. The activation of the NF-kappaB-JNK pathway is independent of the PI3K-Rac1-JNK pathway involved in the bFGF-regulated human fibroblast cell migration. J. Dermatol. Sci. 82(1), 28–37 (2016).
  Medline CASGoogle Scholar
• 60. Liu T, Zhang L, Joo D, Sun SC. NF-kappaB signaling in inflammation. Signal Transduct. Target Ther. 2, 17023 (2017).
  MedlineGoogle Scholar
• 61. Ambrozova N, Ulrichova J, Galandakova A. Models for the study of skin wound healing. The role of Nrf2 and NF-kappaB. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech Repub. 161(1), 1–13 (2017).
  MedlineGoogle Scholar
• 62. Self DJ. The use of animals in medical education and research. Theoret. Med. 10(1), 9–19 (1989).
  Medline CASGoogle Scholar
• 63. Majtan J, Bohova J, Garcia-Villalba R et al. Fir honeydew honey flavonoids inhibit TNF-α-induced MMP-9 expression in human keratinocytes: a new action of honey in wound healing. Arch. Dermatol. Res. 305(7), 619–627 (2013).
  Medline CASGoogle Scholar
• 64. Rothwell JA, Day AJ, Morgan MR. Experimental determination of octanol–water partition coefficients of quercetin and related flavonoids. J. Agric. Food Chem. 53(11), 4355–4360 (2005).
  Medline CASGoogle Scholar
• 65. Monika P, Chandraprabha MN, Rangarajan A et al. Challenges in healing wound: role of complementary and alternative medicine. Front. Nutr. 8, 791899 (2021).
  MedlineGoogle Scholar
• 66. Hamdy A, Ibrahem M. Management of aphthous ulceration with topical quercetin: a randomized clinical trial. J. Contemp. Dent. Pract. 11(4), E009–016 (2010).
  MedlineGoogle Scholar
• 67. Taskan MM, Yuce HB, Karatas O, Gevrek F. Topical quercetin gel application improved wound healing in Wistar rats. Ann. Med. Res. 26(10), 2397–2404 (2019).
  Google Scholar
• 68. Yin G, Wang Z, Wang Z, Wang X. Topical application of quercetin improves wound healing in pressure ulcer lesions. Exp. Dermatol. 27(7), 779–786 (2018).
  Medline CASGoogle Scholar
• 69. Bhatia N, Kaur G, Soni V et al. Evaluation of the wound healing potential of isoquercetin-based cream on scald burn injury in rats. Burns Trauma 4, 7 (2016).
  MedlineGoogle Scholar
• 70. Doersch KM, Newell-Rogers MK. The impact of quercetin on wound healing relates to changes in αV and β1 integrin expression. Exp. Biol. Med. 242(14), 1424–1431 (2017).
  CASGoogle Scholar
• 71. Ahmad A, Imran M, Sharma N. Precision nanotoxicology in drug development: current trends and challenges in safety and toxicity implications of customized multifunctional nanocarriers for drug-delivery applications. Pharmaceutics 14(11), 2463 (2022).
  Medline CASGoogle Scholar
• 72. Tapfumaneyi P, Imran M, Alavi SE, Mohammed Y. Science of, and insights into, thermodynamic principles for dermal formulations. Drug Discov. Today 28(5), 103521 (2023).
  Medline CASGoogle Scholar
• 73. Jin X, Imran M, Mohammed Y. Topical semisolid products-understanding the impact of metamorphosis on skin penetration and physicochemical properties. Pharmaceutics 14(11), 2487 (2022).
  Medline CASGoogle Scholar
• 74. Roberts MS, Cheruvu HS, Mangion SE et al. Topical drug delivery: history, percutaneous absorption, and product development. Adv. Drug Deliv. Rev. 177, 113929 (2021).
  Medline CASGoogle Scholar
• 75. Jangde R, Srivastava S, Singh MR, Singh D. In vitro and in vivo characterization of quercetin loaded multiphase hydrogel for wound healing application. Int. J. Biol. Macromol. 115, 1211–1217 (2018).
  Medline CASGoogle Scholar
• 76. Jee J-P, Pangeni R, Jha SK et al. Preparation and in vivo evaluation of a topical hydrogel system incorporating highly skin-permeable growth factors, quercetin, and oxygen carriers for enhanced diabetic wound-healing therapy. Int. J. Nanomed. 14, 5449 (2019).
  Medline CASGoogle Scholar
• 77. Ajmal G, Bonde GV, Mittal P et al. Biomimetic PCL-gelatin based nanofibers loaded with ciprofloxacin hydrochloride and quercetin: a potential antibacterial and anti-oxidant dressing material for accelerated healing of a full thickness wound. Int. J. Pharm. 567, 118480 (2019).
  Medline CASGoogle Scholar
• 78. Choudhary A, Kant V, Jangir BL, Joshi V. Quercetin loaded chitosan tripolyphosphate nanoparticles accelerated cutaneous wound healing in Wistar rats. Eur. J. Pharm. 880, 173172 (2020).
  Medline CASGoogle Scholar
• 79. Chen Y-B, Zhang Y-B, Wang Y-L et al. A novel inhalable quercetin-alginate nanogel as a promising therapy for acute lung injury. J. Nanobiotechnol. 20(1), 1–17 (2022).
  MedlineGoogle Scholar
• 80. Jangde R, Singh D. Preparation and optimization of quercetin-loaded liposomes for wound healing, using response surface methodology. Artificial Cells Nanomed. Biotechnol. 44(2), 635–641 (2016).
  Medline CASGoogle Scholar
• 81. Gupta A. Nanoemulsions. Nanoparticles for Biomedical Applications. Elsevier, VA, USA, 371–384 (2020).
  Google Scholar
• 82. Solans C, Solé I. Nano-emulsions: formation by low-energy methods. Curr. Opin. Colloid Interface Sci. 17(5), 246–254 (2012).
  CASGoogle Scholar
• 83. Thakur N, Garg G, Sharma P, Kumar N. Nanoemulsions: a review on various pharmaceutical application. Global J. Pharmacol. 6(3), 222–225 (2012).
  Google Scholar
• 84. Bonferoni MC, Rossi S, Sandri G et al. Nanoemulsions for “nose-to-brain” drug delivery. Pharmaceutics 11(2), 84 (2019).
  Medline CASGoogle Scholar
• 85. Sahoo S, Parveen S, Panda J. The present and future of nanotechnology in human health care. Nanomed. Nanotechnol. Biol. Med. 3(1), 20–31 (2007).
  CASGoogle Scholar
• 86. Zorzi GK, Caregnato F, Moreira JCF et al. Antioxidant effect of nanoemulsions containing extract of Achyrocline satureioides (Lam) DC – Asteraceae. AAPS PharmSciTech. 17(4), 844–850 (2016).
  Medline CASGoogle Scholar
• 87. Singh R, Lillard JW Jr. Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol. 86(3), 215–223 (2009).
  Medline CASGoogle Scholar
• 88. Wang W, Lu KJ, Yu CH et al. Nano-drug delivery systems in wound treatment and skin regeneration. J. Nanobiotechnol. 17(1), 82 (2019).
  MedlineGoogle Scholar
• 89. Ribeiro MC, Correa VLR, Silva F et al. Wound healing treatment using insulin within polymeric nanoparticles in the diabetes animal model. Eur. J. Pharm. Sci. 150, 105330 (2020).
  Medline CASGoogle Scholar
• 90. Mohammed Y, Holmes A, Kwok PCL et al. Advances and future perspectives in epithelial drug delivery. Adv. Drug Deliv. Rev. 186, 114293 (2022).
  Medline CASGoogle Scholar
• 91. Bairagi U, Mittal P, Singh J, Mishra B. Preparation, characterization, and in vivo evaluation of nano formulations of ferulic acid in diabetic wound healing. Drug Dev. Ind. Pharm. 44(11), 1783–1796 (2018).
  Medline CASGoogle Scholar
• 92. Robson A-L, Dastoor PC, Flynn J et al. Advantages and limitations of current imaging techniques for characterizing liposome morphology. Front. Pharmacol. 9, 80 (2018).
  MedlineGoogle Scholar
• 93. Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov. Today 8(24), 1112–1120 (2003).
  Medline CASGoogle Scholar
• 94. Akbarzadeh A, Rezaei-Sadabady R, Davaran S et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 8(1), 1–9 (2013).
  MedlineGoogle Scholar
• 95. Manca ML, Matricardi P, Cencetti C et al. Combination of argan oil and phospholipids for the development of an effective liposome-like formulation able to improve skin hydration and allantoin dermal delivery. Int. J. Pharm. 505(1–2), 204–211 (2016).
  Medline CASGoogle Scholar
• 96. Xu HL, Chen PP, ZhuGe DL et al. Liposomes with silk fibroin hydrogel core to stabilize bfgf and promote the wound healing of mice with deep second-degree scald. Adv. Healthc. Mater. 6(19), 1700344 (2017).
  Google Scholar
• 97. Imran M, Iqubal MK, Imtiyaz K et al. Topical nanostructured lipid carrier gel of quercetin and resveratrol: formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer. Int. J. Pharm. 587, 119705 (2020).
  Medline CASGoogle Scholar
• 98. Imran M, Jha SK, Hasan N et al. Overcoming multidrug resistance of antibiotics via nanodelivery systems. Pharmaceutics 14(3), 586 (2022).
  Medline CASGoogle Scholar
• 99. Hasan N, Imran M, Nadeem M et al. Formulation and development of novel lipid-based combinatorial advanced nanoformulation for effective treatment of non-melanoma skin cancer. Int. J. Pharm. 632, 122580 (2023).
  Medline CASGoogle Scholar
• 100. Liu Q, Yang X, Sun J et al. Size-dependent biological effects of quercetin nanocrystals. Molecules 24(7), 1438 (2019).
  Medline CASGoogle Scholar
• 101. Kakran M, Shegokar R, Sahoo NG et al. Long-term stability of quercetin nanocrystals prepared by different methods. J. Pharm. Pharmacol. 64(10), 1394–1402 (2012).
  Medline CASGoogle Scholar
• 102. Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur. J. Pharm. Biopharm. 50(1), 161–177 (2000).
  Medline CASGoogle Scholar
• 103. Khanna K, Sharma N, Rawat S et al. Intranasal solid lipid nanoparticles for management of pain: a full factorial design approach, characterization & gamma scintigraphy. Chem. Phys. Lipids 236, 105060 (2021).
  Medline CASGoogle Scholar
• 104. Hasan N, Imran M, Kesharwani P et al. Intranasal delivery of Naloxone-loaded solid lipid nanoparticles as a promising simple and non-invasive approach for the management of opioid overdose. Int. J. Pharm. 599, 120428 (2021).
  Medline CASGoogle Scholar
• 105. Imran M, Iqubal MK, Imtiyaz K et al. Topical nanostructured lipid carrier gel of quercetin and resveratrol: formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer. Int. J. Pharm. 587, 119705 (2020).
  Medline CASGoogle Scholar
• 106. Makwana V, Jain R, Patel K et al. Solid lipid nanoparticles (SLN) of efavirenz as lymph targeting drug delivery system: elucidation of mechanism of uptake using chylomicron flow blocking approach. Int. J. Pharm. 495(1), 439–446 (2015).
  Medline CASGoogle Scholar
• 107. Sukhotnik I, Moati D, Shaoul R et al. Quercetin prevents small intestinal damage and enhances intestinal recovery during methotrexate-induced intestinal mucositis of rats. Food Nutr. Res. 62, 10.29219/fnr.v62.1327 (2018).
  MedlineGoogle Scholar
• 108. Varrica C, Carvalheiro M, Faria-Silva C et al. Topical allopurinol-loaded nanostructured lipid carriers: a novel approach for wound healing management. Bioengineering (Basel) 8(12), 192 (2021).
  Medline CASGoogle Scholar
• 109. Lee HJ, Jeong M, Na YG et al. An EGF- and curcumin-co-encapsulated nanostructured lipid carrier accelerates chronic-wound healing in diabetic rats. Molecules. 25(20), 4610 (2020).
  Medline CASGoogle Scholar
• 110. Elmowafy M, Al-Sanea MM. Nanostructured lipid carriers (NLCs) as drug delivery platform: advances in formulation and delivery strategies. Saudi Pharm. J. 29(9), 999–1012 (2021).
  Medline CASGoogle Scholar
• 111. Chen H, Wang Y, Zhai Y et al. Development of a ropivacaine-loaded nanostructured lipid carrier formulation for transdermal delivery. Colloids Surf. A Physicochem. Engin. Aspects 465, 130–136 (2015).
  CASGoogle Scholar
• 112. Liu L, Tang Y, Gao C et al. Characterization and biodistribution in vivo of quercetin-loaded cationic nanostructured lipid carriers. Colloids Surf. B Biointerfaces 115, 125–131 (2014).
  Medline CASGoogle Scholar
• 113. Ge X, Wei M, He S, Yuan W-E. Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery. Pharmaceutics 11(2), 55 (2019).
  Medline CASGoogle Scholar
• 114. Khatoon M, Shah KU, Din FU et al. Proniosomes derived niosomes: recent advancements in drug delivery and targeting. Drug Deliv. 24(2), 56–69 (2017).
  Medline CASGoogle Scholar
• 115. Tseng Y-C, Mozumdar S, Huang L. Lipid-based systemic delivery of siRNA. Adv. Drug Deliv. Rev. 61(9), 721–731 (2009).
  Medline CASGoogle Scholar
• 116. Abdelkader H, Alani AW, Alany RG. Recent advances in non-ionic surfactant vesicles (niosomes), self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Deliv. 21(2), 87–100 (2014).
  Medline CASGoogle Scholar
• 117. Jadon PS, Gajbhiye V, Jadon RS et al. Enhanced oral bioavailability of griseofulvin via niosomes. AAPS Pharmscitech. 10(4), 1186–1192 (2009).
  Medline CASGoogle Scholar
• 118. Gharbavi M, Amani J, Kheiri-Manjili H et al. Niosome: a promising nanocarrier for natural drug delivery through blood–brain barrier. Adv. Pharm. Sci. 2018, 6847971 (2018).
  Google Scholar
• 119. Mohapatra A, Uthaman S, Park I-K. Polyethylene glycol nanoparticles as promising tools for anticancer therapeutics. In: Polymeric Nanoparticles as a Promising Tool for Anti-Cancer Therapeutics. Academic Press, CA, USA, 205–231 (2019).
  Google Scholar
• 120. Imran M, Saleem S, Chaudhuri A et al. Docetaxel: an update on its molecular mechanisms, therapeutic trajectory and nanotechnology in the treatment of breast, lung and prostate cancer. J. Drug Deliv. Sci. Technol. 60, 101959 (2020).
  CASGoogle Scholar
• 121. Qiao Z-Y, Zhang R, Du F-S et al. Multi-responsive nanogels containing motifs of ortho ester, oligo (ethylene glycol) and disulfide linkage as carriers of hydrophobic anti-cancer drugs. J. Control. Rel. 152(1), 57–66 (2011).
  Medline CASGoogle Scholar
• 122. Neamtu I, Rusu AG, Diaconu A et al. Basic concepts and recent advances in nanogels as carriers for medical applications. Drug Deliv. 24(1), 539–557 (2017).
  Medline CASGoogle Scholar
• 123. Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat. Mat. 12(11), 991–1003 (2013).
  Medline CASGoogle Scholar
• 124. Zarekar NS, Lingayat VJ, Pande VV. Nanogel as a novel platform for smart drug delivery system. Nanosci. Nanotechnol. 4(1), 25–31 (2017).
  CASGoogle Scholar
• 125. Hajialyani M, Tewari D, Sobarzo-Sanchez E et al. Natural product-based nanomedicines for wound healing purposes: therapeutic targets and drug delivery systems. Int. J. Nanomed. 13, 5023 (2018).
  Medline CASGoogle Scholar
• 126. Anumolu SS, Menjoge AR, Deshmukh M et al. Doxycycline hydrogels with reversible disulfide crosslinks for dermal wound healing of mustard injuries. Biomaterials 32(4), 1204–1217 (2011).
  Medline CASGoogle Scholar
• 127. Li M, Li H, Li X et al. A bioinspired alginate-gum arabic hydrogel with micro-/nanoscale structures for controlled drug release in chronic wound healing. ACS Appl. Mater. Interfaces 9(27), 22160–22175 (2017).
  Medline CASGoogle Scholar
• 128. Mahmoudi M, Gould LJ. Opportunities and challenges of the management of chronic wounds: a multidisciplinary viewpoint. Chron. Wound Care Manage. Res. 7, 27 (2020).
  Google Scholar
• 129. Pierpont YN, Dinh TP, Salas RE et al. Obesity and surgical wound healing: a current review. Int. Scholar. Res. Notices 2014, 638936 (2014).
  Google Scholar
• 130. Landén NX, Li D, Ståhle M. Transition from inflammation to proliferation: a critical step during wound healing. Cell. Mol. Life Sci. 73(20), 3861–3885 (2016).
  Medline CASGoogle Scholar
• 131. Yip WL. Influence of oxygen on wound healing. Int. Wound J. 12(6), 620–624 (2015).
  MedlineGoogle Scholar